Zhu, Xiaofei

Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial. [electronic resource] - BMJ open 12 2016 - e013220 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

2044-6055

10.1136/bmjopen-2016-013220 doi


Antimetabolites, Antineoplastic--administration & dosage
Chemoradiotherapy--methods
Disease-Free Survival
Drug Combinations
Humans
Oxonic Acid--administration & dosage
Pancreatic Neoplasms--pathology
Quality of Life
Radiosurgery--adverse effects
Research Design
Survival Rate
Tegafur--administration & dosage